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ABSTRACT 
Objective To determine the incidence of type 2 diabetes in people with a history of 
hospitalisation for major mental illness versus no mental illness in Scotland, by time 
period and sociodemographics.  
Research design and methods We used national Scottish population-based 
records to create cohorts with a hospital record of schizophrenia, bipolar disorder or 
depression, or no mental illness and to ascertain diabetes incidence. We used quasi-
Poisson regression models including age, sex, time period and area-based 
deprivation to estimate incidence and relative risks (RRs) of diabetes by mental 
illness status. Estimates are illustrated for people aged 60 years and in the middle 
deprivation quintile in 2015. 
Results We identified 254,136 diabetes cases during 2001-2015. Diabetes 
incidence in 2015 was 1.5 to 2.5-fold higher in people with versus without a major 
mental disorder, with the gap having slightly increased over time. RRs of diabetes 
incidence were greater among women than men for schizophrenia (RR 2.40 [95% CI 
2.01, 2.85] and 1.63 [1.38, 1.94]), respectively) and depression (RR 2.10 [1.86, 2.36] 
and 1.62 [1.43, 1.82]), but similar for bipolar disorder (RR 1.65 [1.35, 2.02] and 1.50 
[1.22, 1.84]). Absolute and relative differences in diabetes incidence associated with 
mental illness increased with increasing deprivation.  
Conclusions: Disparities in diabetes incidence between people with and without 
major mental illness appear to be widening. Major mental illness has a greater effect 
on diabetes risk in women and people living in more deprived areas, which has 
implications for intervention strategies to reduce diabetes risk in this vulnerable 
population.  
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INTRODUCTION 
 
The life expectancy of people with major mental illness, including schizophrenia, 
bipolar disorder or major depressive disorder, is reduced by 10-20 years compared 
to the general population (1-3). This excess mortality is largely due to an increased 
risk of cardiovascular disease (3-6), for which type 2 diabetes mellitus is a major risk 
factor. Numerous studies have reported the higher prevalence of diabetes among 
those with a major mental disorder. Recent meta-analyses have demonstrated that, 
although estimates vary substantially across studies, the prevalence of type 2 
diabetes is about 10% in those with schizophrenia and bipolar disorder and 8% in 
those with major depressive disorder (7-10). This relates to about a two-fold 
increased prevalence of diabetes when compared to the general population after 
adjusting for age, and could extend to as much as a three- to four-fold excess risk in 
some sub-groups of the population. However, these estimates are almost entirely 
derived from cross-sectional studies, with few existing prospective studies on the 
incidence of diabetes in those with major mental illness. Where prospective studies 
have been carried out, they focused more on diabetes incidence among people with 
depression (11-13) than schizophrenia or bipolar disorder (14, 15).  
The association between major mental illness and diabetes is explained at least in 
part by key lifestyle factors such as body mass index (BMI) which are known to be 
associated with mental illness and are also major risk factors for type 2 diabetes. 
The relationship between major mental illness and diabetes risk factors might vary 
with age, sex and socioeconomic status, providing the rationale for examining 
whether the association between major mental illness and subsequent diabetes 
might differ by these sociodemographic factors. However this has been little studied 
in prospective studies. Meta-analyses have suggested that the association between 
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depression in general and type 2 diabetes may be more marked in younger than 
older people (11), but this is derived from cross-study comparisons rather than 
investigation of age differences within the same study population. Also, the 
prevalence of co-morbid mental disorder and diabetes prevalence has been 
proposed to be higher in women than men (8, 16), based on cross-sectional data, 
with few prospective studies reporting sex-specific associations of co-morbid mental 
disorder and diabetes. To our knowledge no study has prospectively examined how 
the association between mental illness and type 2 diabetes differs by socioeconomic 
status. Similarly, to our knowledge, there have been no studies of time trends in type 
2 diabetes incidence by major mental illness status and so it is also unclear whether 
the difference in risk has narrowed or widened over time.  
Therefore, in the present study we examined incidence of type 2 diabetes in 
Scotland from 2001-2015 among those with a prior hospital record for major mental 
illness versus those without a history of hospitalisation for any mental health 
disorder, exploring differences by time period, age, sex and socioeconomic status. 
METHODS  
We used the dataset of the General Acute inpatient and Day Case - Scottish 
Morbidity Records (SMR01) and the Mental Health Inpatient and Day Case dataset 
(SMR04) to identify hospital admissions where the discharge diagnoses included 
schizophrenia (International Statistical Classification of Diseases [ICD] 10 F20 and 
F25 and ICD9 295.0 to 295.3, 295.6 to 295.9), bipolar disorder (ICD10 F30 to F31 
and ICD9 296.0 to 296.1, 296.4 to 296.7) or depression (ICD10 F32-F34 and ICD9 
296.2 to 296.3, 298.0, 311). We initially carried out exploratory analyses to 
investigate whether associations differed for people with an uncomplicated mental 
illness (i.e. diagnosis of a single mental illness) and complex mental illness (i.e. 
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diagnoses of multiple mental illnesses). The patterns of associations were broadly 
similar. Hence, we applied a hierarchy of severity to assign people to one group only, 
ranking disorders as schizophrenia, bipolar disorder and depression; thus, someone 
with a record of both bipolar disorder and depression was assigned to the bipolar 
group only. Individuals entered the cohort from the date of first hospital admission for 
the most severe of the three disorders. We identified prevalent cases of mental 
health disorder among those aged 18 years or older between 1st January 1981 and 
31st December 2014.  
Comparison cohort 
Our comparison cohort was derived from the total general population, after removing 
people who had a hospital record for any mental illness listed in ICD10 chapter 5 
(mental and behavioural disorders) or the corresponding ICD9 codes, with the 
exception of organic disorders (F00-F09) and mental retardation (F70-F79). Details 
of the ICD codes used are provided in Supplementary Table S1.  
Type 2 diabetes  
We identified incident cases of type 2 diabetes through a research extract of the 
Scottish Care Information – Diabetes (SCI-Diabetes) dataset. This national diabetes 
register includes approximately 99% of all patients diagnosed with diabetes since 
2004 (17), collating information from primary and secondary care clinics on clinical 
care, demographic and lifestyle factors. It also includes information on people 
diagnosed with diabetes between 2001 and 2004 and who did not die during that 
time period. For research purposes, an algorithm is used to differentiate between 
type 1 and type 2 diabetes, based on clinician-recorded diagnosis, prescription data 
and age at diabetes diagnosis. In this study, we included all incident type 2 diabetes 
cases occurring between 1st January 2001 and 31st December 2015   
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Person-time 
We calculated person-time (in fractional years) for the mental health cohort from the 
date of hospital admission with a mental health disorder until the end date of follow 
up. We followed the cohort until the earliest of type 2 diabetes diagnosis date, date 
of death, or end of follow-up (31st December 2015). We obtained person-time for the 
comparison population via mid-year estimates of the population. Person-time after 
an event was subtracted from the estimates in each year. 
Events and person-time were broken down by calendar year, age in 5-years 
categories, sex and area-based deprivation. The latter was defined using quintiles of 
the Carstairs Index, which uses census data at postcode level on lack of car 
ownership, low occupational social class, overcrowded households and male 
unemployment to create a measure of material deprivation of an area (18).  
Statistical analyses 
We summarised baseline characteristics for the complete cohort and calculated age-
standardised type 2 diabetes incidence rates, per 1000 person-years (pyrs), using 
the 2013 European Standard Population (see http://www.isdscotland.org/Products-
and-Services/GPD-Support/Population/Standard-Populations/ for more details). We 
fitted quasi-Poisson models with incidence of type 2 diabetes as the outcome, which 
included main effects for history of a mental illness, age, sex, time period and area-
based deprivation index and all two-way interactions. Age (using the mid-point of 
each 5-year block) and time period were modelled as continuous variables using 
natural cubic splines. Area-based deprivation index was modelled as a categorical 
variable. The models were used to calculate relative risks (RRs). All analyses were 
conducted using R software (19). 
Ethics approval 
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Approval for the linkage of the administrative health datasets used in this study was 
provided by the NHS Scotland Public Benefit and Privacy Panel for Health and 
Social Care. Approval for the use of diabetes data was obtained from the Scottish 
Diabetes Research Network and ethics approval was obtained from the South East 
Scotland Research Ethics Committee (reference 16/SS/0152). 
This article is written in accordance with the Strengthening Reporting of 
Observational Studies in Epidemiology (STROBE) (20) and Reporting of Studies 
Conducted using Observational Routinely-collected health data (RECORD) (21) 
statements. 
RESULTS 
Between 2001 and 2015 there were 246,046 incident type 2 diabetes mellitus cases 
in Scotland among people with no prior hospital record of a mental illness and 2315 
among those with a hospital record for schizophrenia, 1720 among those with bipolar 
disorder and 4055 among those with depression.  
Type 2 diabetes incidence by mental health status, age and sex 
Type 2 diabetes incidence increased with increasing age (until about 60 years) in all 
groups, peaking at an earlier age among people with a mental disorder compared to 
those with no history of mental illness. Thus, the average age of type 2 diabetes 
onset was lower in people with an admission for schizophrenia (mean 51.4 years ± 
12.6 SD) and depression (mean 57.6 ± 13.1 SD), but not bipolar disorder (mean 60.0 
± 12.1 SD) compared to the population with no mental illness (mean 60.8 ± 13.2 SD; 
Table 1). In all comparison groups, age of onset was slightly younger in men than 
women and in the most versus least deprived in all groups. The age-standardised 
incidence of type 2 diabetes at all time points was higher among people with a 
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hospital record for each mental disorder than the group without mental illness (Table 
2). This concurred with predicted incidence rates obtained from quasi-Poisson 
models, as illustrated in Figure 1, which shows type 2 diabetes incidence by age for 
the middle deprivation quintile, in 2001 and 2015. Absolute rates of type 2 diabetes 
were higher in men than women in all cohorts, although the difference in incidence 
was smaller for people with schizophrenia and bipolar disorder (Figure 1).  
Time-trends in diabetes incidence by mental disorder 
Between 2001 and 2015, age-standardised type 2 diabetes incidence decreased 
overall in the group with no history of mental illness, in both men and women. Among 
those with schizophrenia and bipolar disorder, type 2 diabetes incidence increased 
between 2001 and 2008 and then started to decrease up to 2015. In contrast, 
incidence of type 2 diabetes increased between 2001 and 2015 among people with a 
hospital record for depression. These findings are illustrated in supplementary Figure 
1 using data from men and women aged 60 years and in the middle deprivation 
quintile. We observed similar patterns of type 2 diabetes incidence among those 
aged 40 and 50 years (especially for depression), although there was less of a 
decline in incidence in the cohort without mental illness compared to the 60 year-olds 
and diabetes incidence tended to plateau from 2008 onwards in people with 
schizophrenia and bipolar disorder (supplementary Figure 2). In general, having a 
hospital record for each mental disorder was associated with increased incidence of 
type 2 diabetes when compared to the group without mental illness. For example, in 
2015, among men aged 60 years and in the middle deprivation quintile, type 2 
diabetes incidence was higher in those with schizophrenia (RR 1.63, 95% CI 1.38 to 
1.94), in men with bipolar disorder (RR 1.50, 95% CI 1.22 to 1.84) and in men with 
depression (RR 1.62, 95% CI 1.43 to 1.82), compared to the group with no mental 
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illness (Table 3). RRs were greater among women than men, with incidence of type 2 
diabetes in 2015 almost two-and-a-half-fold higher in women with schizophrenia (RR 
2.40, 95% CI 2.01 to 2.85), 65% higher in those with bipolar disorder (RR 1.65, 95% 
CI 1.35, to 2.02) and two-fold higher in those with depression (RR 2.10, 95% CI 1.86 
to 2.36) compared to the group with no mental illness (Table 3). Among both men 
and women, RRs compared to the group without mental illness among those aged 
60 years increased over time for the schizophrenia, depression and, to a lesser 
extent, bipolar disorder cohorts (Table 3 and supplementary Figure 3). RR estimates 
over time followed similar patterns at ages 40 and 50 years (Supplementary Figure 
4). 
Type 2 diabetes incidence by mental disorder, sex and deprivation level 
The proportion of people in the most deprived quintile was much higher in the 
cohorts with schizophrenia (32.8%), bipolar disorder (27.0%) and depression 
(27.0%) than the comparison group (21.7%; Table 1). Type 2 diabetes incidence was 
positively associated with deprivation among women in all cohorts and men with a 
mental disorder (Table 4 and Supplementary Figure 5). We did not observe a 
deprivation gradient in type 2 diabetes incidence among men without mental illness 
at 60 years of age. For all disorders, the RR of type 2 diabetes incidence was 
greatest among people in the most deprived quintiles (Table 4). For instance, in 2015 
the RR for type 2 diabetes incidence in 60 year-old men with versus without 
schizophrenia in the most deprived quintile was 1.69 (95% CI 1.45 to 1.98) whereas 
the association for men with versus without schizophrenia in the least deprived 
quintile was not statistically significant (RR 1.09, 95% CI 0.88 to 1.36). A similar 
pattern was observed among men with bipolar disorder and depression. RRs for 
women were larger than men for all mental disorder groups. As with men, RRs were 
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positively associated with deprivation, but in contrast to men, the association was 
statistically significant in the least deprived group. For example, schizophrenia was 
associated with a two-and-a-half-fold (RR 2.48, 95% CI 2.12 to 2.91) and a 60% (RR 
1.60, 95% CI 1.28 to 2.01) increased risk of type 2 diabetes incidence in the most 
and least deprived quintiles, respectively (Table 4). We observed similar deprivation 
gradients in type 2 diabetes among men and women aged 40 and 60 years with 
mental illness, with the deprivation pattern also evident among men without mental 
illness at age 40 (but not 60) years (supplementary Figure 6). 
The larger relative risks in women than men are only partly due to lower absolute 
rates of diabetes in women than men, since we observed a greater difference in type 
2 diabetes incidence among those with versus without schizophrenia (and to a lesser 
degree, depression) in women compared to men (supplementary Figure 7). 
Therefore, having a hospital record for schizophrenia or depression is more strongly 
associated with incidence of type 2 diabetes in women than men in all deprivation 
groups, but particularly the most deprived groups. 
CONCLUSIONS 
Main findings 
In Scotland, having a hospital admission for major mental illness is associated with a 
one-and-a-half to two-and-a-half-fold higher risk of type 2 diabetes incidence, with 
RRs for those with compared to those without mental illness appearing to have 
increased over the last 15 years. In people with a hospital admission for 
schizophrenia or depression, type 2 diabetes incidence occurs at a younger age 
compared to people without a hospital admission for major mental illness. We found 
important sociodemographic differences, with the absolute and relative effects of 
mental illness being stronger in women than men and in deprived sub-groups, 
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indicating a greater impact of mental illness on type 2 diabetes risk in women and in 
people living in more deprived areas.  
Strengths and limitations 
To our knowledge, this is the first study to examine time trends in type 2 diabetes 
incidence by mental health disorder status, the first to examine differences in 
incidence by socioeconomic status and one of the first to investigate whether the 
prospective association differs by age and sex. Other strengths include the objective 
ascertainment of a diagnosis of type 2 diabetes, which was more than 99% complete 
from 2004 onwards, being based on a national diabetes register which collates 
information from primary care and secondary care clinics. The national scale and 
long-term running of the diabetes register also led to the inclusion of large numbers 
of diabetes cases, thus facilitating the investigation of interaction by time, age, sex 
and socioeconomic status.  
Our study does however have some shortcomings. The main limitation is that, in the 
absence of national primary care data for research purposes, our definitions of major 
mental disorders were based on hospital records only. Therefore our findings may 
not be generalizable to those with a mental disorder who have never had their 
disorder recorded in hospital. This limitation is mitigated by the fact that hospital 
records extend as far back as 1981. Since we used both psychiatric and general 
hospital admission records to identify people with depression, there may have been 
selection bias in that people with less severe depression may have been included 
purely because they were admitted to a general hospital for an unrelated 
disease/episode. It is difficult to speculate how the definition of depression might 
have affected the results, since it could have both over-estimated the association 
between depression and diabetes (if a dose-response relationship exists between 
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depression and diabetes risk) or under-estimated the association since people with 
depression that has not been recorded in hospital would not have been identified. 
Also, it is possible that those with a major mental disorder and admitted to hospital 
would be more likely to have their diabetes diagnosed, purely through having more 
contact with the health service. Also, we were not able to identify whether the 
associations differed depending on whether the mental illness diagnosis was 
recorded from psychiatric or acute hospital medical records; it would be of interest to 
explore this in future research. Finally, we were unable to adjust for factors known to 
be associated with mental illness and to be major risk factors for type 2 diabetes, 
such as use of psychotropic medications, sleep disruption, low physical activity and 
poor dietary choices that influence BMI, the key risk factor for type 2 diabetes. 
However, given that BMI may lie on the causal pathway between mental illness and 
type 2 diabetes, one could argue that minimally adjusted estimates more accurately 
convey the associated risk of diabetes. Data on BMI were not available for the cohort 
so it was not possible to investigate potential mediation. 
Interpretation in context of previous studies 
Despite the limitations of our study, our findings are consistent with previous 
prospective studies on the association between major mental disorders and type 2 
diabetes incidence. In general, cohort studies have found that depression is 
associated with a 30-100% increased risk of type 2 diabetes prior to adjustment for 
lifestyle factors (11-13) and schizophrenia and bipolar disorder with a 70-80% 
increased risk of type 2 diabetes (14).  
The slight decline in type 2 diabetes incidence observed among those with no 
hospital record for mental illness in our study is in line with overall trends in diabetes 
incidence in the general Scottish population (22). Since 2004, type 2 diabetes 
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incidence in Scotland has declined or stabilised, depending on sex, age and 
socioeconomic status, which is thought to be attributed to stabilising obesity 
prevalence and intensified diagnosis of type 2 diabetes leading to a smaller number 
and proportion of undiagnosed type 2 diabetes cases (22). However, our study 
demonstrates that this stabilisation or decline in type 2 diabetes incidence has not 
been observed among people with major mental illness. The reasons for the excess 
risk of type 2 diabetes in people with a major mental disorder are multi-factorial and 
complex, including environmental, genetic and lifestyle factors. Potential side effects 
of drug treatments for mental illness are also important, with antipsychotic and anti-
depressant medication having been linked to type 2 diabetes via weight gain and 
other metabolic abnormalities (23, 24). Furthermore, mental illness itself may have a 
direct physiological effect. For instance, there is evidence of glucose homeostasis 
disruption among antipsychotic-naïve individuals presenting with first episode 
schizophrenia (25).  Many mechanisms ultimately increase risk of obesity, the key 
risk factor for type 2 diabetes. The apparent increase in diabetes incidence over time 
among those with a major mental illness in our study could be due to a number of 
factors, including improved diabetes diagnosis in this group over time. Primary care 
screening for cardiometabolic disease in general and among people with mental 
illness was incentivised through the Quality and Outcomes Framework, a pay-for-
performance scheme for general practitioners, which was in place in Scotland 
between 2004 and April 2017 (26). This offered a financial reward to promote good 
practice against a set of evidence-based indicators, including monitoring of 
cardiometabolic risk in people with mental illness. The increase in type 2 diabetes 
incidence among those with schziophrenia might also reflect the introduction, and 
more widespread use, of second generation antipsychotics, which, compared to first 
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generation antipsychotics are thought to be associated with a slightly higher 
increased risk of type 2 diabetes, via weight gain or effects on insulin resistance (27). 
However, it has been shown that all antipsychotics are associated with weight gain, 
albeit to varying degrees (28).  
The observed sex differences in our study are interesting. A systematic review of 
studies found no sex difference in type 2 diabetes prevalence in people with and 
without bipolar disorder, which is in line with our findings on incidence (9). A later 
review by the same authors pooled together studies of patients with schizophrenia, 
bipolar disorder and major depression and found that prevalence of diabetes was 
about 40% higher in women than men (8), but since the analyses combined all 
mental disorders, it is unclear how sex differences might have differed by mental 
disorder. Consistent with our findings on depression, a recent prospective study 
reported greater effects of depression on type 2 diabetes risk in women than men 
(29). One explanation for our findings could be the higher prevalence of obesity in 
women with these mental health disorders compared to men and the larger relative 
gap in obesity between those with and without mental illness in women compared to 
men (30). It is intriguing that we did not observe similarly pronounced sex differences 
in the bipolar disorder group, given similar patterns of obesity by sex in this group.  
As with sex, previous studies have tended to adjust for socioeconomic status, rather 
than investigate potential interactions between mental disorders and socioeconomic 
status. Our findings indicate that, for all mental health disorders, the absolute and 
relative difference in diabetes rates are exacerbated by increasing level of 
deprivation, highlighting the additional vulnerability of people with a mental illness 
who live in deprived areas. Previous Scottish studies have found that the excess 
mortality associated with severe mental illness is most marked in the most deprived 
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population groups (31), and that multimorbidity, including mental-physical health 
comorbidity is more prevalent among more deprived groups (32). By demonstrating 
that the association between mental disorder and type 2 diabetes varies markedly by 
deprivation level, our study suggests that this increased diabetes risk is due largely 
to modifiable factors rather than intrinsic physiological effects of the mental illness 
itself.  
Implications 
The temporal and sociodemographic variations in the association between major 
mental disorders and diabetes have important implications for both clinical care and 
intervention strategies aimed at equitable improvement of physical health in people 
with mental illness. Sex and socioeconomic differences highlight the particularly high 
increased risk of type 2 diabetes among women and people living in more deprived 
areas with a mental illness. Reasons for these variations are likely multi-factorial and 
should be investigated further in future studies. Higher prevalence of obesity in 
women compared to men with mental illness could account for some of the observed 
sex differences in the association between mental illness and type 2 diabetes 
incidence. The importance of monitoring and attempting to improve the 
cardiometabolic health of people with major mental illness (and in particular, women 
and people with a low socioeconomic status) should continue to be emphasised to 
psychiatrists and primary care physicians. Novel intervention approaches aimed at 
reducing type 2 diabetes risk in people with mental illness should be tailored 
accordingly and involve targeted as well as universal strategies. Factors related to 
both socioeconomic status and mental illness, and amenable to intervention, include 
provision of care (33), health literacy (34), engagement with health services (35) and 
lifestyle behaviour. Whilst improvement of each of these is undoubtedly challenging, 
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these must all be tackled if we are to reduce the risk of type 2 diabetes in people with 
mental illness, particularly in more deprived areas. Furthermore, more pharmaco-
epidemiological studies are urgently needed to improve our understanding of the 
potential adverse metabolic consequences of antipsychotics, mood stabilisers and 
anti-depressants. In an era of precision medicine, advances in the refined tailoring of 
psychotropic drug prescribing practices to optimise control of mental health 
symptoms and minimise side-effects on physical health may be possible in the 
future.        
Conclusion 
In Scotland, major mental illness is associated with a marked increased risk of 
incidence of type 2 diabetes, with evidence of increasing disparities in the last 15 
years. The absolute and relative effects of mental illness are stronger in women than 
men and in more deprived sub-groups. These findings provide important insights into 
temporal and sociodemographic differences in type 2 diabetes risk across multiple 
mental health disorders, which have implications for clinical care and intervention 
strategies.    
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Table 1 Characteristics of people with incident type 2 diabetes, by mental health disorder, in Scotland 2000-2015 
Characteristic 
No mental illness  Schizophrenia  Bipolar disorder  Depression  
(N = 246,046) (N = 2315) (N = 1720) (N = 4055) 
Male (%) 136,753 (55.6) 1361 (58.8) 683 (39.7) 1664 (41.0) 
Mean age at type 2 diabetes 
onset, years (± SD): All; 60.8 (± 13.2) 51.4 (± 12.6)  60.0 (± 12.1)  57.6 (± 13.1)  
[men: women] [59.6 (± 13.7) : 62.3 ± 13.7] [49.1 ± 11.8 : 54.7 ± 12.9] [59.5 ± 11.9 : 60.3 ± 12.2] [56.8 ± 12.3 : 58.1 ± 60.3] 
Area-based deprivation* 
quintile 
    
  1 (most deprived) 53,350 (21.7) 759 (32.8) 464 (27.0) 1094 (27.0) 
  2 51,519 (20.9) 496 (21.4) 335 (19.5) 927 (22.9) 
  3 50,702 (20.6) 445 (19.2) 326 (19.0) 822 (20.3) 
  4 47,275 (19.2) 358 (15.5) 318 (18.5) 679 (16.7) 
  5 (least deprived) 43,200 (17.6) 257 (11.1) 277 (16.1) 533 (13.1) 
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Table 2 Age-standardised* incidence of type 2 diabetes, by mental illness cohort, sex and 
time-period 
Time period 
Age-standardised type 2 diabetes incidence rate, per 1000 person-years* (95% CI) 
No mental illness Schizophrenia Bipolar disorder Depression 
MEN 
   
2001-2005 4.92 (4.88, 4.97) 6.56 (5.86, 7.27) 6.52 (5.65, 7.38) 5.24 (4.69, 5.79) 
2006-2010 4.94 (4.90, 4.99) 8.26 (7.50, 9.01) 6.72 (5.85, 7.59) 5.78 (5.29, 6.26) 
2011-2015 4.49 (4.45, 4.53) 8.61 (7.90, 9.31) 7.12 (6.21, 8.03) 6.46 (6.00, 6.91) 
WOMEN 
    
2001-2005 3.64 (3.61, 3.68) 6.95 (6.13, 7.78) 5.17 (4.63, 5.70) 5.17 (4.74, 5.60) 
2006-2010 3.42 (3.38, 3.45) 7.89 (7.03, 8.75) 5.37 (4.80, 5.94) 5.10 (4.74, 5.46) 
2011-2015 3.02 (2.99, 3.05) 8.60 (7.71, 9.50) 5.17 (4.61, 5.73) 5.74 (5.40, 6.09) 
*Standardised to the European Standard Population 
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Table 3 Relative risks ratios for type 2 diabetes at 5-yearly intervals, among people aged 60 and in the middle deprivation quintile, comparing 
people with hospitalisation for each mental disorder versus no mental illness, by sex and year, based on predictive values from quasi-Poisson 
regression models 
 
Year 
Men Women 
Schizophrenia Bipolar disorder Depression Schizophrenia Bipolar disorder Depression 
2001 1.07 (0.89, 1.29) 1.24 (1.02, 1.52) 1.09 (0.94, 1.26) 1.57 (1.30, 1.89) 1.37 (1.13, 1.66) 1.41 (1.22, 1.63) 
2005 1.29 (1.12, 1.49) 1.37 (1.17, 1.61) 1.18 (1.06, 1.31) 1.89 (1.64, 2.18) 1.51 (1.30, 1.76) 1.53 (1.38, 1.69) 
2010 1.53 (1.33, 1.77) 1.49 (1.27, 1.75) 1.34 (1.21, 1.49) 2.25 (1.94, 2.60) 1.64 (1.40, 1.92) 1.74 (1.57, 1.93) 
2015 1.63 (1.38, 1.94) 1.50 (1.22, 1.84) 1.62 (1.43, 1.82) 2.40 (2.01, 2.85) 1.65 (1.35, 2.02) 2.10 (1.86, 2.36) 
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Table 4 Relative risks (with 95% confidence intervals) for type 2 diabetes in people aged 60, comparing people with a hospitalisation record for 
each mental disorder versus no mental illness, by sex and area-based deprivation quintile, in Scotland in 2010 and 2015 
Year 
Deprivation 
quintile 
Men Women 
Rate ratio (95% CI) Rate ratio (95% CI) 
Schizophrenia Bipolar disorder Depression Schizophrenia Bipolar disorder Depression 
  2010 1 (most deprived) 1.59 (1.40, 1.80) 1.88 (1.61, 2.18) 1.39 (1.26, 1.54) 2.33 (2.05, 2.64) 2.06 (1.79, 2.37) 1.81 (1.65, 1.98) 
 
2 1.64 (1.44, 1.88) 1.71 (1.46, 2.00) 1.48 (1.34, 1.64) 2.41 (2.10, 2.76) 1.88 (1.62, 2.18) 1.92 (1.74, 2.11) 
 
3 1.53 (1.33, 1.77) 1.49 (1.27, 1.75) 1.34 (1.21, 1.49) 2.25 (1.94, 2.60) 1.64 (1.40, 1.92) 1.74 (1.57, 1.93) 
 
4 1.17 (0.99, 1.39) 1.35 (1.14, 1.60) 1.10 (0.98, 1.23) 1.72 (1.45, 2.04) 1.49 (1.26, 1.76) 1.42 (1.27, 1.60) 
 
5 (least deprived) 1.03 (0.84, 1.25) 1.12 (0.93, 1.35) 0.96 (0.83, 1.10) 1.50 (1.23, 1.84) 1.23 (1.02, 1.48) 1.25 (1.08, 1.43) 
  2015 1 (most deprived) 1.69 (1.45, 1.98) 1.89 (1.55, 2.29) 1.68 (1.50, 1.88) 2.48 (2.12, 2.91) 2.08 (1.72, 1.50) 2.18 (1.96, 2.43) 
 
2 1.75 (1.49, 2.06) 1.72 (1.41, 2.10) 1.78 (1.59, 2.00) 2.57 (2.18, 3.03) 1.89 (1.56, 2.30) 2.31 (2.07, 2.59) 
 
3 1.63 (1.38, 1.94) 1.50 (1.22, 1.84) 1.62 (1.43, 1.82) 2.40 (2.01, 2.85) 1.65 (1.35, 2.02) 2.10 (1.86, 2.36) 
 
4 1.25 (1.03, 1.52) 1.36 (1.10, 1.68) 1.32 (1.16, 1.51) 1.83 (1.51, 2.23)  1.50 (1.22, 1.85) 1.72 (1.51, 1.96) 
 
5 (least deprived) 1.09 (0.88, 1.36) 1.13 (0.90, 1.41) 1.16 (0.99, 1.35) 1.60 (1.28, 2.01) 1.24 (0.99, 1.55) 1.50 (1.29, 1.75) 
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FIGURE LEGENDS 
Figure 1 Type 2 diabetes incidence* among people in the middle deprivation quintile, 
for 2001 and 2015, by age, type or absence of mental disorder and sex 
*Predicted incidence rates obtained from quasi-Poisson regression models including mental health status, age, sex, 
deprivation and time period, plus all mental health status and age interactions 
